Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3K Buy
+12,732
New +$9.82K ﹤0.01% 1360
2026
Q1
Sell
-11,375
Closed -$15.4K 1256
2025
Q4
$15.4K Buy
+11,375
New +$11.5K ﹤0.01% 985
2022
Q4
Sell
-38
Closed -$3.06K 760
2022
Q3
$3.06K Buy
+38
New +$5.45K ﹤0.01% 527

Other funds holding YCBD

StoneX Group's YCBD Position: Q2 2026 in Review

StoneX Group opened a new position in cbdMD (YCBD) in Q2 2026: 12,732 shares worth $10.3K. The stake represents ﹤0.01% of the portfolio and ranks #1360 among its holdings. This is a return to the name: StoneX Group previously reported a position in YCBD as recently as Q4 2025.

StoneX Group first reported a position in YCBD in Q3 2022 and has held it in 3 quarters since. The position peaked at $15.4K in Q4 2025. 27 funds tracked by Wall St. Rank hold YCBD as of Q2 2026.

  • StoneX Group held 12,732 shares of cbdMD worth $10.3K as of Q2 2026.
  • cbdMD was a new StoneX Group position in Q2 2026.
  • cbdMD made up ﹤0.01% of StoneX Group's portfolio in Q2 2026, its #1360 holding.
  • StoneX Group first reported a position in cbdMD in Q3 2022 and has held it in 3 quarters since.
  • StoneX Group's cbdMD position peaked at $15.4K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held cbdMD as of Q2 2026.

Based on StoneX Group's 13F filing for Q2 2026, filed 12 Aug 2026.